Do analysts recommend PHG or MDLN?

Medline has a consensus price target of $50.54, suggesting a potential upside of 30.73%. Given Medline's stronger consensus rating and higher probable upside, analysts plainly believe Medline is more favorable than Koninklijke Philips. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Koninklijke Philips 0 Sell rating(s) 4 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Medline 1 Sell rating(s) 5 Hold rating(s) 22 Buy rating(s) 1 Strong Buy rating(s) 2.79

Does the media favor PHG or MDLN?

In the previous week, Medline had 7 more articles in the media than Koninklijke Philips. MarketBeat recorded 9 mentions for Medline and 2 mentions for Koninklijke Philips. Medline's average media sentiment score of 0.85 beat Koninklijke Philips' score of 0.00 indicating that Medline is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Koninklijke Philips 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Medline 4 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend PHG or GEHC?

GE HealthCare Technologies has a consensus target price of $79.48, suggesting a potential upside of 28.89%. Given GE HealthCare Technologies' stronger consensus rating and higher probable upside, analysts clearly believe GE HealthCare Technologies is more favorable than Koninklijke Philips. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Koninklijke Philips 0 Sell rating(s) 4 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 GE HealthCare Technologies 0 Sell rating(s) 10 Hold rating(s) 10 Buy rating(s) 0 Strong Buy rating(s) 2.50

Does the media favor PHG or GEHC?

In the previous week, GE HealthCare Technologies had 10 more articles in the media than Koninklijke Philips. MarketBeat recorded 12 mentions for GE HealthCare Technologies and 2 mentions for Koninklijke Philips. GE HealthCare Technologies' average media sentiment score of 0.68 beat Koninklijke Philips' score of 0.00 indicating that GE HealthCare Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Koninklijke Philips 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral GE HealthCare Technologies 2 Very Positive mention(s) 0 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate ZBH or PHG?

Zimmer Biomet currently has a consensus target price of $102.33, indicating a potential upside of 12.58%. Given Zimmer Biomet's stronger consensus rating and higher probable upside, equities analysts clearly believe Zimmer Biomet is more favorable than Koninklijke Philips. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Zimmer Biomet 3 Sell rating(s) 13 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 2.25 Koninklijke Philips 0 Sell rating(s) 4 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media favor ZBH or PHG?

In the previous week, Zimmer Biomet had 10 more articles in the media than Koninklijke Philips. MarketBeat recorded 12 mentions for Zimmer Biomet and 2 mentions for Koninklijke Philips. Zimmer Biomet's average media sentiment score of 0.93 beat Koninklijke Philips' score of 0.00 indicating that Zimmer Biomet is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Zimmer Biomet 5 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Koninklijke Philips 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate PHG or SOLV?

Solventum has a consensus price target of $83.67, suggesting a potential upside of 9.76%. Given Solventum's stronger consensus rating and higher probable upside, analysts clearly believe Solventum is more favorable than Koninklijke Philips. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Koninklijke Philips 0 Sell rating(s) 4 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Solventum 1 Sell rating(s) 6 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.43

Does the media favor PHG or SOLV?

In the previous week, Solventum had 7 more articles in the media than Koninklijke Philips. MarketBeat recorded 9 mentions for Solventum and 2 mentions for Koninklijke Philips. Solventum's average media sentiment score of 1.25 beat Koninklijke Philips' score of 0.00 indicating that Solventum is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Koninklijke Philips 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Solventum 6 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate PHG or SNN?

Smith & Nephew SNATS has a consensus price target of $30.93, suggesting a potential upside of 3.73%. Given Smith & Nephew SNATS's stronger consensus rating and higher probable upside, analysts plainly believe Smith & Nephew SNATS is more favorable than Koninklijke Philips. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Koninklijke Philips 0 Sell rating(s) 4 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Smith & Nephew SNATS 0 Sell rating(s) 5 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.17

Which has stronger valuation & earnings, PHG or SNN?

Koninklijke Philips has higher revenue and earnings than Smith & Nephew SNATS. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Koninklijke Philips $20.17B 1.27 $1.01B $1.17 22.29 Smith & Nephew SNATS $6.16B 2.04 $625M N/A N/A

Does the media refer more to PHG or SNN?

In the previous week, Smith & Nephew SNATS had 3 more articles in the media than Koninklijke Philips. MarketBeat recorded 5 mentions for Smith & Nephew SNATS and 2 mentions for Koninklijke Philips. Smith & Nephew SNATS's average media sentiment score of 0.96 beat Koninklijke Philips' score of 0.00 indicating that Smith & Nephew SNATS is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Koninklijke Philips 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Smith & Nephew SNATS 3 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Koninklijke Philips (PHG) Competitors

$26.08 -1.26 (-4.62%)

Closing price 03:59 PM Eastern

Extended Trading

$26.05 -0.03 (-0.10%)

As of 05:14 PM Eastern

Compare

PHG vs. MDLN, GEHC, ZBH, SOLV, and SNN

Should you buy Koninklijke Philips stock or one of its competitors? MarketBeat compares Koninklijke Philips with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Koninklijke Philips include Medline (MDLN), GE HealthCare Technologies (GEHC), Zimmer Biomet (ZBH), Solventum (SOLV), and Smith & Nephew SNATS (SNN). These companies are all part of the "medical equipment" industry.

How does Koninklijke Philips compare to Medline?

Koninklijke Philips (NYSE:PHG) and Medline (NASDAQ:MDLN) are both large-cap medical equipment companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, dividends, risk, institutional ownership, earnings, media sentiment, analyst recommendations and profitability.

Medline has a consensus price target of $50.54, suggesting a potential upside of 30.73%. Given Medline's stronger consensus rating and higher probable upside, analysts plainly believe Medline is more favorable than Koninklijke Philips.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Koninklijke Philips	0 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Medline	1 Sell rating(s)	5 Hold rating(s)	22 Buy rating(s)	1 Strong Buy rating(s)	2.79

Koninklijke Philips has a net margin of 5.49% compared to Medline's net margin of 0.00%. Koninklijke Philips' return on equity of 13.51% beat Medline's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Koninklijke Philips	5.49%	13.51%	5.48%
Medline	N/A	N/A	N/A

In the previous week, Medline had 7 more articles in the media than Koninklijke Philips. MarketBeat recorded 9 mentions for Medline and 2 mentions for Koninklijke Philips. Medline's average media sentiment score of 0.85 beat Koninklijke Philips' score of 0.00 indicating that Medline is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Koninklijke Philips	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Medline	4 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

13.7% of Koninklijke Philips shares are held by institutional investors. 0.8% of Medline shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Medline has higher revenue and earnings than Koninklijke Philips. Koninklijke Philips is trading at a lower price-to-earnings ratio than Medline, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Koninklijke Philips	$20.17B	1.27	$1.01B	$1.17	22.29
Medline	$28.43B	1.79	$1.16B	$0.32	120.81

Summary

Medline beats Koninklijke Philips on 11 of the 16 factors compared between the two stocks.

How does Koninklijke Philips compare to GE HealthCare Technologies?

Koninklijke Philips (NYSE:PHG) and GE HealthCare Technologies (NASDAQ:GEHC) are both large-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, media sentiment, valuation, institutional ownership, earnings, dividends, profitability and analyst recommendations.

13.7% of Koninklijke Philips shares are held by institutional investors. Comparatively, 82.1% of GE HealthCare Technologies shares are held by institutional investors. 0.4% of GE HealthCare Technologies shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, GE HealthCare Technologies had 10 more articles in the media than Koninklijke Philips. MarketBeat recorded 12 mentions for GE HealthCare Technologies and 2 mentions for Koninklijke Philips. GE HealthCare Technologies' average media sentiment score of 0.68 beat Koninklijke Philips' score of 0.00 indicating that GE HealthCare Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Koninklijke Philips	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
GE HealthCare Technologies	2 Very Positive mention(s)	0 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Koninklijke Philips has a beta of 0.75, meaning that its share price is 25% less volatile than the broader market. Comparatively, GE HealthCare Technologies has a beta of 0.72, meaning that its share price is 28% less volatile than the broader market.

Koninklijke Philips pays an annual dividend of $0.84 per share and has a dividend yield of 3.2%. GE HealthCare Technologies pays an annual dividend of $0.14 per share and has a dividend yield of 0.2%. Koninklijke Philips pays out 71.8% of its earnings in the form of a dividend. GE HealthCare Technologies pays out 3.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. GE HealthCare Technologies has raised its dividend for 1 consecutive years.

GE HealthCare Technologies has a consensus target price of $79.48, suggesting a potential upside of 28.89%. Given GE HealthCare Technologies' stronger consensus rating and higher probable upside, analysts clearly believe GE HealthCare Technologies is more favorable than Koninklijke Philips.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Koninklijke Philips	0 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
GE HealthCare Technologies	0 Sell rating(s)	10 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.50

GE HealthCare Technologies has higher revenue and earnings than Koninklijke Philips. GE HealthCare Technologies is trading at a lower price-to-earnings ratio than Koninklijke Philips, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Koninklijke Philips	$20.17B	1.27	$1.01B	$1.17	22.29
GE HealthCare Technologies	$20.63B	1.36	$2.08B	$4.18	14.75

GE HealthCare Technologies has a net margin of 9.10% compared to Koninklijke Philips' net margin of 5.49%. GE HealthCare Technologies' return on equity of 20.46% beat Koninklijke Philips' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Koninklijke Philips	5.49%	13.51%	5.48%
GE HealthCare Technologies	9.10%	20.46%	5.73%

Summary

GE HealthCare Technologies beats Koninklijke Philips on 16 of the 19 factors compared between the two stocks.

How does Koninklijke Philips compare to Zimmer Biomet?

Zimmer Biomet (NYSE:ZBH) and Koninklijke Philips (NYSE:PHG) are both large-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, valuation, risk, institutional ownership, profitability, media sentiment and dividends.

88.9% of Zimmer Biomet shares are held by institutional investors. Comparatively, 13.7% of Koninklijke Philips shares are held by institutional investors. 1.3% of Zimmer Biomet shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Zimmer Biomet has a net margin of 9.05% compared to Koninklijke Philips' net margin of 5.49%. Koninklijke Philips' return on equity of 13.51% beat Zimmer Biomet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zimmer Biomet	9.05%	13.24%	7.28%
Koninklijke Philips	5.49%	13.51%	5.48%

In the previous week, Zimmer Biomet had 10 more articles in the media than Koninklijke Philips. MarketBeat recorded 12 mentions for Zimmer Biomet and 2 mentions for Koninklijke Philips. Zimmer Biomet's average media sentiment score of 0.93 beat Koninklijke Philips' score of 0.00 indicating that Zimmer Biomet is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Zimmer Biomet	5 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Koninklijke Philips	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Zimmer Biomet pays an annual dividend of $0.96 per share and has a dividend yield of 1.1%. Koninklijke Philips pays an annual dividend of $0.84 per share and has a dividend yield of 3.2%. Zimmer Biomet pays out 24.9% of its earnings in the form of a dividend. Koninklijke Philips pays out 71.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Zimmer Biomet has a beta of 0.46, indicating that its stock price is 54% less volatile than the broader market. Comparatively, Koninklijke Philips has a beta of 0.75, indicating that its stock price is 25% less volatile than the broader market.

Koninklijke Philips has higher revenue and earnings than Zimmer Biomet. Koninklijke Philips is trading at a lower price-to-earnings ratio than Zimmer Biomet, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zimmer Biomet	$8.23B	2.14	$705.20M	$3.85	23.61
Koninklijke Philips	$20.17B	1.27	$1.01B	$1.17	22.29

Zimmer Biomet currently has a consensus target price of $102.33, indicating a potential upside of 12.58%. Given Zimmer Biomet's stronger consensus rating and higher probable upside, equities analysts clearly believe Zimmer Biomet is more favorable than Koninklijke Philips.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zimmer Biomet	3 Sell rating(s)	13 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.25
Koninklijke Philips	0 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Zimmer Biomet beats Koninklijke Philips on 14 of the 19 factors compared between the two stocks.

How does Koninklijke Philips compare to Solventum?

Koninklijke Philips (NYSE:PHG) and Solventum (NYSE:SOLV) are both large-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, media sentiment, institutional ownership, risk and analyst recommendations.

Koninklijke Philips has a beta of 0.75, meaning that its stock price is 25% less volatile than the broader market. Comparatively, Solventum has a beta of 0.66, meaning that its stock price is 34% less volatile than the broader market.

Solventum has a net margin of 17.33% compared to Koninklijke Philips' net margin of 5.49%. Solventum's return on equity of 23.51% beat Koninklijke Philips' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Koninklijke Philips	5.49%	13.51%	5.48%
Solventum	17.33%	23.51%	7.63%

In the previous week, Solventum had 7 more articles in the media than Koninklijke Philips. MarketBeat recorded 9 mentions for Solventum and 2 mentions for Koninklijke Philips. Solventum's average media sentiment score of 1.25 beat Koninklijke Philips' score of 0.00 indicating that Solventum is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Koninklijke Philips	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Solventum	6 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

13.7% of Koninklijke Philips shares are held by institutional investors. 0.2% of Solventum shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Solventum has lower revenue, but higher earnings than Koninklijke Philips. Solventum is trading at a lower price-to-earnings ratio than Koninklijke Philips, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Koninklijke Philips	$20.17B	1.27	$1.01B	$1.17	22.29
Solventum	$8.33B	1.59	$1.56B	$8.16	9.34

Solventum has a consensus price target of $83.67, suggesting a potential upside of 9.76%. Given Solventum's stronger consensus rating and higher probable upside, analysts clearly believe Solventum is more favorable than Koninklijke Philips.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Koninklijke Philips	0 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Solventum	1 Sell rating(s)	6 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.43

Summary

Solventum beats Koninklijke Philips on 12 of the 16 factors compared between the two stocks.

How does Koninklijke Philips compare to Smith & Nephew SNATS?

Koninklijke Philips (NYSE:PHG) and Smith & Nephew SNATS (NYSE:SNN) are both large-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, analyst recommendations, dividends, valuation, profitability and institutional ownership.

Koninklijke Philips has a beta of 0.75, indicating that its share price is 25% less volatile than the broader market. Comparatively, Smith & Nephew SNATS has a beta of 0.56, indicating that its share price is 44% less volatile than the broader market.

13.7% of Koninklijke Philips shares are held by institutional investors. Comparatively, 25.6% of Smith & Nephew SNATS shares are held by institutional investors. 1.0% of Smith & Nephew SNATS shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Koninklijke Philips has a net margin of 5.49% compared to Smith & Nephew SNATS's net margin of 0.00%. Koninklijke Philips' return on equity of 13.51% beat Smith & Nephew SNATS's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Koninklijke Philips	5.49%	13.51%	5.48%
Smith & Nephew SNATS	N/A	N/A	N/A

Koninklijke Philips pays an annual dividend of $0.84 per share and has a dividend yield of 3.2%. Smith & Nephew SNATS pays an annual dividend of $0.93 per share and has a dividend yield of 3.1%. Koninklijke Philips pays out 71.8% of its earnings in the form of a dividend.

Smith & Nephew SNATS has a consensus price target of $30.93, suggesting a potential upside of 3.73%. Given Smith & Nephew SNATS's stronger consensus rating and higher probable upside, analysts plainly believe Smith & Nephew SNATS is more favorable than Koninklijke Philips.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Koninklijke Philips	0 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Smith & Nephew SNATS	0 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.17

In the previous week, Smith & Nephew SNATS had 3 more articles in the media than Koninklijke Philips. MarketBeat recorded 5 mentions for Smith & Nephew SNATS and 2 mentions for Koninklijke Philips. Smith & Nephew SNATS's average media sentiment score of 0.96 beat Koninklijke Philips' score of 0.00 indicating that Smith & Nephew SNATS is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Koninklijke Philips	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Smith & Nephew SNATS	3 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Koninklijke Philips has higher revenue and earnings than Smith & Nephew SNATS.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Koninklijke Philips	$20.17B	1.27	$1.01B	$1.17	22.29
Smith & Nephew SNATS	$6.16B	2.04	$625M	N/A	N/A

Summary

Smith & Nephew SNATS beats Koninklijke Philips on 9 of the 16 factors compared between the two stocks.

Get Koninklijke Philips News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PHG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PHG vs. The Competition

Export

Metric	Koninklijke Philips	MED PRODUCTS Industry	Medical Sector	NYSE Exchange
Market Cap	$26.87B	$8.67B	$6.85B	$23.45B
Dividend Yield	3.08%	2.54%	2.68%	4.02%
P/E Ratio	22.35	15.65	27.04	31.16
Price / Sales	1.27	6.99	524.25	19.78
Price / Cash	8.85	18.09	48.59	24.88
Price / Book	2.02	3.56	10.80	4.78
Net Income	$1.01B	$228.19M	$3.59B	$1.07B
7 Day Performance	-7.55%	-3.20%	-2.24%	-0.04%
1 Month Performance	-1.29%	-1.55%	3.12%	0.07%
1 Year Performance	8.36%	-3.53%	26.30%	16.91%

Koninklijke Philips Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PHG Koninklijke Philips	1.8792 of 5 stars	$26.08 -4.6%	N/A	+13.8%	$26.87B	$20.17B	22.35	65,340	Gap Down
MDLN Medline	4.091 of 5 stars	$42.75 -1.0%	$50.54 +18.2%	N/A	$56.74B	$28.43B	N/A	45,000
GEHC GE HealthCare Technologies	4.9691 of 5 stars	$64.84 -1.1%	$80.20 +23.7%	-13.1%	$29.82B	$20.63B	15.51	54,000	Analyst Forecast
ZBH Zimmer Biomet	3.5891 of 5 stars	$89.75 +2.6%	$102.70 +14.4%	+0.2%	$16.92B	$8.23B	23.31	17,000
SOLV Solventum	4.0163 of 5 stars	$77.87 -0.5%	$83.73 +7.5%	+5.1%	$13.55B	$8.33B	12.54	20,000	News Coverage Positive News Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:PHG) was last updated on 7/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Koninklijke Philips (PHG) Competitors

PHG vs. MDLN, GEHC, ZBH, SOLV, and SNN

How does Koninklijke Philips compare to Medline?

Summary

How does Koninklijke Philips compare to GE HealthCare Technologies?

Summary

How does Koninklijke Philips compare to Zimmer Biomet?

Summary

How does Koninklijke Philips compare to Solventum?

Summary

How does Koninklijke Philips compare to Smith & Nephew SNATS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PHG vs. The Competition

Koninklijke Philips Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Koninklijke Philips (PHG) Competitors

PHG vs. MDLN, GEHC, ZBH, SOLV, and SNN

How does Koninklijke Philips compare to Medline?

Do analysts recommend PHG or MDLN?

Is PHG or MDLN more profitable?

Does the media favor PHG or MDLN?

Do insiders and institutionals hold more shares of PHG or MDLN?

Which has stronger earnings and valuation, PHG or MDLN?

Summary

How does Koninklijke Philips compare to GE HealthCare Technologies?

Do insiders & institutionals believe in PHG or GEHC?

Does the media favor PHG or GEHC?

Which has more volatility & risk, PHG or GEHC?

Is PHG or GEHC a better dividend stock?

Do analysts recommend PHG or GEHC?

Which has better valuation and earnings, PHG or GEHC?

Is PHG or GEHC more profitable?

Summary

How does Koninklijke Philips compare to Zimmer Biomet?

Do insiders and institutionals hold more shares of ZBH or PHG?

Is ZBH or PHG more profitable?

Does the media favor ZBH or PHG?

Is ZBH or PHG a better dividend stock?

Which has more risk & volatility, ZBH or PHG?

Which has stronger earnings & valuation, ZBH or PHG?

Do analysts rate ZBH or PHG?

Summary

How does Koninklijke Philips compare to Solventum?

Which has more risk & volatility, PHG or SOLV?

Is PHG or SOLV more profitable?

Does the media favor PHG or SOLV?

Do institutionals and insiders hold more shares of PHG or SOLV?

Which has stronger valuation & earnings, PHG or SOLV?

Do analysts rate PHG or SOLV?

Summary

How does Koninklijke Philips compare to Smith & Nephew SNATS?

Which has more volatility and risk, PHG or SNN?

Do institutionals & insiders have more ownership in PHG or SNN?

Is PHG or SNN more profitable?

Is PHG or SNN a better dividend stock?

Do analysts rate PHG or SNN?

Does the media refer more to PHG or SNN?

Which has stronger valuation & earnings, PHG or SNN?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PHG vs. The Competition

Koninklijke Philips Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools